MiR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

26Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Background: MicroRNAs (miRNAs) were reportedly to play crucial roles in papillary thyroid carcinoma (PTC) tumorigenesis and development. Therefore, the discovery of miRNAs may provide a new and powerful tool for diagnosis and treatment of PTC. Purpose: The aim of this study was to investigate the biological function and underlying mechanism of miR-622 in PTC. Materials and methods: The expression levels of miR-622 in PTC patient tissues and cell lines were determined by quantitative RT-PCR (qRT-PCR). The biological function including cell proliferation, colony formation, migration and invasion, as well as underling mechanism of miR-622 in PTC, were also evaluated by a series of in vitro and in vivo experiments. Results: miR-622 expression level was significantly downregulated in PTC tissues and cell lines. Decreased miR-622 expression was associated with advanced clinical stage and lymph node metastasis (P,0.01). The overexpression of miR-622 in TPC-1 cells inhibited cell proliferation, migration and invasion in vitro, as well as suppress tumor growth in vivo. Moreover, we also demonstrated that miR-622 specifically targeted the 3′-UTR regions of vascular endothelial growth factor A (VEGFA) and inhibited its expression both mRNA level and protein levels. Overexpression of VEGFA reversed miR-622-mediated inhibition effect on cell proliferation, migration and invasion in thyroid cancer cells. More importantly, VEGFA expression was significantly increased and inversely correlated with the levels of miR-622 in PTC tissues. Conclusion: These results show that miR-622 acts as a tumor suppressor in thyroid cancer, at least in part, via targeting VEGFA, and suggest that miR-622 may serves as a potential target for treatment of thyroid cancer patients.

Cite

CITATION STYLE

APA

Wang, R., Ma, Q., Ji, L., Yao, Y., Ma, M., & Wen, Q. (2018). MiR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma. OncoTargets and Therapy, 11, 1501–1509. https://doi.org/10.2147/OTT.S156810

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free